Evidence mapPaperPMID 37727922Full record

ArticleYonsei medical journal2023

Hyperpolarized [1-

Young-Suk Choi, Jae Eun Song, Eosu Kim, Chul Hoon Kim, Jong Eun Lee, Ho-Taek Song

Open access · goldAbstract read
In one paragraph

Article in Yonsei medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Young-Suk ChoiDepartment of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-4930-8455
Jae Eun SongDepartment of Radiology, Stanford University, Palo Alto, CA, USA.ORCID https://orcid.org/0000-0002-7616-543X
Eosu KimDepartment of Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-9472-9465
Chul Hoon KimDepartment of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7360-429X
Jong Eun LeeBK21 PLUS Project for Medical Sciences and Brain Research Institute, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6203-7413
Ho-Taek SongDepartment of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea. hotsong@yuhs.ac.ORCID https://orcid.org/0000-0002-6655-2575
Yonsei University · KRPalo Alto University · US

Funding

Korea Health Industry Development Institute HI14C2173National Research Foundation of Korea 2020R1I1A1A01065063Yonsei University College of Medicine 6-2021-0237
6 · The paper itself

Abstract

purposeType 2 diabetes mellitus (T2DM) is associated with a 2-fold increased risk of developing Alzheimer's disease. In earlier research, agmatine has been demonstrated to alleviate diabetes symptoms and increase cognitive performance. However, it is unclear whether the improvement of cognitive function is attributable to the reduction of diabetic symptoms or its direct influence on brain metabolism. Using hyperpolarized (HP) [1- MATERIALS AND

methodsICR mice were fed a high-fat diet and injected with streptozotocin to develop a T2DM animal model. During a 2-week period, T2DM mice were treated with normal saline or 100 mg/kg of agmatine, and brain HP [1-

resultsAs a perfusion marker, the total

conclusionAgmatine influences the NADH/NAD+ redox state in the brains of T2DM mice, which may be connected with enhanced cognitive performance and increased conversion of HP [1-

Indexed as

AgmatineDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2AnimalsBrainLactic AcidMiceMice, Inbred ICRNADPyruvic AcidAgmatineLactic AcidNADPyruvic AcidagmatineAlzheimer's diseasehyperpolarizedlactatemagnetic resonance spectroscopy

Identifiers

PMID37727922
PMCPMC10522877
OpenAlexW4386809853

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.